drugset / Trial / NCT02753504
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety/tolerability and pharmacokinetics/pharmacodynamics of CKD-519
Timeline
- Start
- 2016-04
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ROCACETRAPIB | Small molecule | 50 mg | Oral |
| Subject | ROCACETRAPIB | Small molecule | 100 mg | Oral |
| Subject | ROCACETRAPIB | Small molecule | 200 mg | Oral |